160 related articles for article (PubMed ID: 19874981)
1. Risk factors and outcomes of Candida albicans and non-albicans Candida species at a Thai tertiary care center.
Apisarnthanarak A; Naknarongkij N; Kiratisin P; Mundy LM
Am J Infect Control; 2009 Nov; 37(9):781-2. PubMed ID: 19874981
[No Abstract] [Full Text] [Related]
2. Fungemia in non-HIV-infected patients: a five-year review.
Anunnatsiri S; Chetchotisakd P; Mootsikapun P
Int J Infect Dis; 2009 Jan; 13(1):90-6. PubMed ID: 18653367
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007.
Nace HL; Horn D; Neofytos D
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):289-94. PubMed ID: 19376670
[TBL] [Abstract][Full Text] [Related]
4. Comment: Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients.
Vandijck DM; Blot SI; Decruyenaere JM
Ann Pharmacother; 2007 Nov; 41(11):1916-7; author reply 1917. PubMed ID: 17911209
[No Abstract] [Full Text] [Related]
5. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
6. Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital.
Yapar N; Uysal U; Yucesoy M; Cakir N; Yuce A
Mycoses; 2006 Mar; 49(2):134-8. PubMed ID: 16466448
[TBL] [Abstract][Full Text] [Related]
7. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
8. Candida species, genotypes and antifungal susceptibility of Candida isolates from blood samples of patients at the largest tertiary care hospital in Thailand during 1999-2002.
Foongladda S; Sakulmaiwatana P; Petlum P; Vanprapar N
J Med Assoc Thai; 2004 Jan; 87(1):92-9. PubMed ID: 14971541
[TBL] [Abstract][Full Text] [Related]
9. Nosocomial candidaemia in children: results of a 9-year study.
Celebi S; Hacimustafaoglu M; Ozdemir O; Ozkaya G
Mycoses; 2008 May; 51(3):248-57. PubMed ID: 18399906
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients.
Davis SL; Vazquez JA; McKinnon PS
Ann Pharmacother; 2007 Apr; 41(4):568-73. PubMed ID: 17374623
[TBL] [Abstract][Full Text] [Related]
11. Secular trends of candidemia in a tertiary care hospital.
Sampaio Camargo TZ; Marra AR; Silva CV; Cardoso MF; Martino MD; Camargo LF; Correa L
Am J Infect Control; 2010 Sep; 38(7):546-51. PubMed ID: 20736114
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Candida species in different hospital wards and their susceptibility to antifungal agents: results of a three year survey.
Fadda ME; Podda GS; Pisano MB; Deplano M; Cosentino S
J Prev Med Hyg; 2008 Jun; 49(2):69-74. PubMed ID: 18847180
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
[TBL] [Abstract][Full Text] [Related]
14. Distribution of Candida species among bloodstream isolates.
Al-Jasser AM; Elkhizzi NA
Saudi Med J; 2004 May; 25(5):566-9. PubMed ID: 15138521
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective.
Colombo AL
Braz J Infect Dis; 2000 Jun; 4(3):113-8. PubMed ID: 10934493
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiological features of Candida infections detected in intensive care units and risk factors affecting mortality].
Acar A; Oncül O; Küçükardali Y; Ozyurt M; Haznedaroğlu T; Cavuşlu S
Mikrobiyol Bul; 2008 Jul; 42(3):451-61. PubMed ID: 18822889
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiological study of invasive nosocomial candidiasis in 2 teaching hospitals in Beijing].
Cao B; Wang H; Wu L; Sun WJ; Li F; Liu YM
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1970-3. PubMed ID: 19062737
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and outcome for nosocomial breakthrough candidaemia.
Pasqualotto AC; Nedel WL; Machado TS; Severo LC
J Infect; 2006 Mar; 52(3):216-22. PubMed ID: 15936825
[TBL] [Abstract][Full Text] [Related]
19. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.
Trick WE; Fridkin SK; Edwards JR; Hajjeh RA; Gaynes RP;
Clin Infect Dis; 2002 Sep; 35(5):627-30. PubMed ID: 12173140
[TBL] [Abstract][Full Text] [Related]
20. [Opportunistic Candida albicans infections in the critically ill patient].
de las Mulas M; López T; Capurro M; Verdejo A; Castaño F
Rev Esp Anestesiol Reanim; 1982 Nov; 29(6):300-5. PubMed ID: 7170367
[No Abstract] [Full Text] [Related]
[Next] [New Search]
